UMB Bank’s Pacira BioSciences PCRX Stock Holding History

UMB Bank’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.66K	Buy	383 +40	+12%	+$889	﹤0.01%	1909
2025 Q4	$8.88K	Buy	343 +20	+6%	+$476	﹤0.01%	1860
2025 Q3	$8.32K	Sell	323 -118	-27%	-$2.9K	﹤0.01%	1747
2025 Q2	$10.5K	Sell	441 -2	-0.5%	-$50	﹤0.01%	1586
2025 Q1	$11K	Buy	443 +66	+18%	+$1.58K	﹤0.01%	1516
2024 Q4	$7.1K	Buy	377 +74	+24%	+$1.3K	﹤0.01%	1591
2024 Q3	$4.56K	Sell	303 -72	-19%	-$1.23K	﹤0.01%	1760
2024 Q2	$10.7K	Buy	375 +31	+9%	+$882	﹤0.01%	1253
2024 Q1	$10.1K	Buy	344 +20	+6%	+$614	﹤0.01%	1275
2023 Q4	$10.9K	Sell	324 -272	-46%	-$7.96K	﹤0.01%	1263
2023 Q3	$18.3K	Hold	596	–	–	﹤0.01%	1108
2023 Q2	$23.9K	Hold	596	–	–	﹤0.01%	1051
2023 Q1	$24.3K	Hold	596	–	–	﹤0.01%	1035
2022 Q4	$23K	Hold	596	–	–	﹤0.01%	1073
2022 Q3	$32K	Buy	596 +30	+5%	+$1.67K	﹤0.01%	976
2022 Q2	$33K	Hold	566	–	–	﹤0.01%	1017
2022 Q1	$43K	Buy	566 +149	+36%	+$9.93K	﹤0.01%	1010
2021 Q4	$25K	Buy	+417	New	+$23K	﹤0.01%	1206

Other funds holding PCRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return